|Year : 2019 | Volume
| Issue : 5 | Page : 5-6
Review of activities of society of nuclear medicine India, 2019
Ashish Kumar Jha
Secretary, Society of Nuclear Medicine India, C/o Radiation Medicine Centre; Department of Nuclear Medicine and Molecular Imaging, Tata Memorial Hospital, Parel, Mumbai - 400 012, Maharashtra, India
|Date of Web Publication||26-Nov-2019|
Ashish Kumar Jha
Secretary, Society of Nuclear Medicine India, C/o Radiation Medicine Centre; Department of Nuclear Medicine and Molecular Imaging, Tata Memorial Hospital, Parel, Mumbai - 400 012, Maharashtra
Source of Support: None, Conflict of Interest: None
|How to cite this article:|
Jha AK. Review of activities of society of nuclear medicine India, 2019. Indian J Nucl Med 2019;34, Suppl S1:5-6
|How to cite this URL:|
Jha AK. Review of activities of society of nuclear medicine India, 2019. Indian J Nucl Med [serial online] 2019 [cited 2020 Aug 7];34, Suppl S1:5-6. Available from: http://www.ijnm.in/text.asp?2019/34/5/5/271613
Pleased to share that the Society of Nuclear Medicine India (SNMI) has completed 50 years of inception and excellence in 2018. The golden jubilee celebration which had begun 2 years back is coming to an end with the 51st Annual Conference of SNMI (SNMICON-2019) in Mumbai from December 12–15, 2019. The celebration is huge and will witness our incredible and glorious past of our Society. SNMI has been working relentlessly to improve the nuclear medicine practice and patient care in India by rendering opportunities to the professionals to improve their skills through Continuing Medical Education (CME) and conferences organized under the aegis of SNMI. Nuclear medicine is a multidisciplinary subject where nuclear medicine physician works in a close association with nuclear medical physicist, radiochemist, scientist, and technologists to deliver quality service to the patients. SNMI is the association of nuclear medicine physicians, physicists radiochemists, scientists, and technologists and dedicated to work for the progress of all. As the tenure of executive committee of SNMI comes to an end, we reflect on the changes brought about since we took office in January 2018. In the past 2 years, we have worked on various fronts to ensure sustainable development of our professionals and reliable service to the patient through our society.
| Interaction With International Societies|| |
The SNMI represents Nuclear Medicine in India and abroad. SNMI is recognized as the Indian representative in the world nuclear medicine forum. Considering this fact, we have strengthened our relationships with important international nuclear medicine associations such as SNMMI, EANM, ARCCNM, and JSNM. This year, we had stall at SNMMI and EANM and SNMI president had a separate meeting with SNMMI president and his committee in SNMMI annual meeting. We have opened the negotiation table to most of the international nuclear medicine societies to negotiate mutual cooperation. We are committed to improve our international relations in future.
| Subspecialty Management Groups|| |
- Various subspecialty management groups (SMGs) were created and they are working on the development of procedural guidelines and conducting CMEs to improve the quality of nuclear medicine practice in India.
- In the near future, we are going to publish Indian guidelines to harmonize nuclear medicine practice in our country.
| Constitution of Update and Amendment Committee|| |
- Constituted committee has had several round of meetings
- Committee has finished the work of the update and amendment of constitution
- This year, we are bringing CUA bill in the special GBM of SNMI during SNMICON-2019.
| Session With Regulatory and Other Authorities' Authority|| |
- In the last 2 years, we have been engaged with our regulators and other authorities several times to facilitate the nuclear medicine professionals
- We have also worked toward improvement in legislation to facilitate the growth of Nuclear Medicine practices in India
- We have represented our society in the office of Drug Controller General of India (DCGI), AERB, MCI, and other regulators to protect our profession and professionals.
| Sustainable Delivery of Radioisotopes|| |
- In the last few years, we experienced the intermittent interruption of supply of molybdenum-99 technetium-99m generator in our country due to implementation of stipulated import rules by DCGI. The interruption in the supply chain of radioisotope, particularly molybdenum-99 technetium-99m generator, impacted private and government sector equally and eventually led to compromised patient care
- SNMI took up the responsibility and approached the DCGI regarding this issue and after several meetings issues related to import of radioisotope resolved
- To maintain the sustainability of radioisotope supply to nuclear medicine department, we requested DCGI to form an advisory committee in drug controller's office consisting nuclear medicine professionals working in government and private both, which will advise DCGI in related matters
- Honorable DCGI agreed to our proposal and constituted a nuclear medicine committee, which will advise DCGI on various issues related to nuclear medicine and radiopharmaceuticals in the future and ensure sustainable supply of radioisotope to nuclear medicine department in our country.
I show my sincere gratitude to all the members of our society for believing in us and giving an opportunity to serve. Furthermore, I would like to thank all the members of SMGs and constitution update and amendment committee for their support to our program to improve member's services through them. Last but not least, I would like to thank the entire Executive committee (SNMI) for their unconditional support.
Once again, we would like to assure of our commitments and dedication toward the betterment of the Nuclear Medicine Society.